全文获取类型
收费全文 | 2484篇 |
免费 | 76篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 22篇 |
妇产科学 | 12篇 |
基础医学 | 342篇 |
口腔科学 | 136篇 |
临床医学 | 202篇 |
内科学 | 491篇 |
皮肤病学 | 40篇 |
神经病学 | 490篇 |
特种医学 | 90篇 |
外科学 | 277篇 |
综合类 | 17篇 |
一般理论 | 1篇 |
预防医学 | 100篇 |
眼科学 | 21篇 |
药学 | 161篇 |
中国医学 | 2篇 |
肿瘤学 | 134篇 |
出版年
2023年 | 15篇 |
2022年 | 8篇 |
2021年 | 26篇 |
2020年 | 23篇 |
2019年 | 30篇 |
2018年 | 50篇 |
2017年 | 11篇 |
2016年 | 35篇 |
2015年 | 34篇 |
2014年 | 66篇 |
2013年 | 70篇 |
2012年 | 163篇 |
2011年 | 161篇 |
2010年 | 92篇 |
2009年 | 90篇 |
2008年 | 145篇 |
2007年 | 169篇 |
2006年 | 173篇 |
2005年 | 195篇 |
2004年 | 152篇 |
2003年 | 181篇 |
2002年 | 155篇 |
2001年 | 43篇 |
2000年 | 32篇 |
1999年 | 49篇 |
1998年 | 42篇 |
1997年 | 37篇 |
1996年 | 32篇 |
1995年 | 24篇 |
1994年 | 19篇 |
1993年 | 27篇 |
1992年 | 26篇 |
1991年 | 13篇 |
1990年 | 20篇 |
1989年 | 6篇 |
1988年 | 12篇 |
1987年 | 15篇 |
1986年 | 14篇 |
1985年 | 6篇 |
1984年 | 10篇 |
1983年 | 11篇 |
1982年 | 7篇 |
1981年 | 6篇 |
1979年 | 8篇 |
1977年 | 5篇 |
1976年 | 5篇 |
1975年 | 7篇 |
1974年 | 7篇 |
1971年 | 4篇 |
1970年 | 4篇 |
排序方式: 共有2566条查询结果,搜索用时 31 毫秒
81.
Voiding and sexual dysfunction after deep rectal resection and total mesorectal excision 总被引:3,自引:0,他引:3
Sterk P Shekarriz B Günter S Nolde J Keller R Bruch HP Shekarriz H 《International journal of colorectal disease》2005,20(5):423-427
OBJECTIVE: Voiding and sexual dysfunction after deep rectal resection have been described with various frequencies in the literature. In this study, we prospectively evaluated the baseline preoperative voiding and sexual function in a cohort of patients undergoing deep rectal resection with mesorectal excision to determine any pre-existing abnormalities. Postoperatively, we sought first to determine the frequency of a urinary or sexual dysfunction, secondly whether there is a time-dependent change of a dysfunction and thirdly whether there is a relationship between postoperative urological dysfunction and the patient's age. PATIENTS AND METHODS: Fifty-two patients (36 men and 16 women) with a primary rectal carcinoma were prospectively examined directly before and after the operation, as well after the third and sixth postoperative month. The preoperative urological evaluation consisted of a careful voiding and sexual history, uroflowmetry and a sonographic residual urine determination. A detailed sexual history was obtained via the use of a questionnaire. RESULTS: Urological dysfunction: Preoperatively, 49 of the 52 patients had a completely normal bladder function and three patients had post void residual >100 ml. Postoperatively, 12 of the 49 patients with normal preoperatively urinary function had voiding dysfunction, but only four male patients had residual urine in the third postoperative month. Therefore, in about 90% of the patients, postoperative bladder function became normal and only 10% suffered from vesical denervation after 6 months. We could not determine a relationship between the degree of bladder dysfunction and the patient's age due to a relatively small patient cohort in this study. Sexual dysfunction: Preoperatively, 36 (seven women, 29 men) of the 52 patients were potent and had regular sexual intercourse. Eleven men specified a limited erection, but all had occasional sexual intercourse. One of the potent men experienced no ejaculation. Postoperatively, eight of the 29 men were impotent and two of the 29 men experienced retrograde ejaculation. Therefore, 30% of the preoperatively potent men had sexual dysfunction postoperatively. There was no correlation between the postoperative impotence and the age of the patients at the time of surgery. Although it is likely that the potency may diminish with advanced age, the incidence of impotence was not higher in the older patients of our study. CONCLUSIONS: The results of our study underline the importance of risk estimation for possible postoperative urological dysfunction by means of preoperative urologic evaluation in this patient collective. Of patients with postoperative bladder dysfunction, 90% improved within 6 months after surgery and only 10% continued to have bladder dysfunction beyond 6 months, indicating irreversible nerve damage. 相似文献
82.
Hanns F. Lhr Jrg F. Schlaak Guido Gerken Bernhard Fleischer Hans-Peter Dienes Karl-Hermann Meyer zum Büschenfelde 《Liver international》1994,14(3):161-166
Cytokines released by infiltrating T cells may contribute to the hepatic injury in chronic hepatitis. Therefore, we characterized peripheral blood- and liver-infiltrating T cells from patients with chronic hepatitis of different etiology and determined the T cell phenotypes and the cytokine release. Liver tissue and peripheral blood-derived T cells from patients with autoimmune hepatitis and primary biliary cirrhosis predominantly expressed CD4-molecules and the α- and β-chains of the T cell receptor (TCR). In chronic viral hepatitis B and C, liver- and blood-derived T cells were preferentially CD8+ T cells expressing the αβ TCR. Mitogenic stimulation with irradiated Daudi lymphoma cells and phytohemagglutinin led to a strong release of interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α) and interleukin-2 (IL-2) by T cells in patients with chronic hepatitis and in healthy controls. T cells from patients with primary biliary cirrhosis and some patients with autoimmune hepatitis showed a significantly higher secretion of interleukin-4 (IL-4) and interleukin-10 (IL-10) than T cells from patients with chronic viral hepatitis or healthy controls. Histologic inflammatory activity did not correlate with the amount of cytokines released after mitogenic activation. In conclusion, liver tissue and peripheral blood T cells of patients with autoimmune hepatitis and primary biliary cirrhosis were dominated by CD4+ TCR αβ+ T helper/inducer cells, whereas in chronic viral hepatitis an enrichment of CD8+ TCR αβ+ cytotoxic/suppressor T cells was observed. In addition, analysis of the cytokine release showed that T cells in autoimmune and chronic viral liver diseases secreted high amounts of IFN-γ and TNF-α, cytokines predominantly secreted by Thl-like cells. The secretion of the Th2 cytokines. IL-4 and IL-10, however, was increased in autoimmune hepatitis and primary biliary cirrhosis. These data show that in autoimmune and chronic viral liver diseases different functional T cell subsets are activated. 相似文献
83.
Georg Osterhoff Max J. ScheyererYannick Fritz Samy BouaichaGuido A. Wanner Hans-Peter SimmenClément M.L. Werner 《Injury》2014
Introduction
Radiology-based classifications of pelvic ring injuries and their relevance for the prognosis of morbidity and mortality are disputed in the literature. The purpose of this study was to evaluate potential differences between the pelvic ring injury classification systems by Tile and by Young and Burgess with regard to their predictive value on mortality, transfusion/infusion requirement and concomitant injuries.Patients and methods
Two-hundred-and-eighty-five consecutive patients with pelvic ring fractures were analyzed for mortality within 30 days after admission, number of blood units and total volume of fluid infused during the first 24 h after trauma, the Abbreviated Injury Severity (AIS) scores for head, chest, spine, abdomen and extremities as a function of the Tile and the Young–Burgess classifications.Results
There was no significant relationship between occurrence of death and fracture pattern but a significant relationship between fracture pattern and need for blood units/total fluid volume for Tile (p < .001/p < .001) and Young–Burgess (p < .001/p < .001). In both classifications, open book fractures were associated with more fluid requirement and more severe injuries of the abdomen, spine and extremities (p < .05). When divided into the larger subgroups “partially stable” and “unstable”, unstable fractures were associated with a higher mortality rate in the Young–Burgess system (p = .036). In both classifications, patients with unstable fractures required significantly more blood transfusions (p < .001) and total fluid infusion (p < .001) and higher AIS scores.Conclusions
In this first direct comparison of both classifications, we found no clinical relevant differences with regard to their predictive value on mortality, transfusion/infusion requirement and concomitant injuries. 相似文献84.
85.
Katinka Albrecht Klaus Krüger Jürgen Wollenhaupt Rieke Alten Marina Backhaus Christoph Baerwald Wolfgang Bolten Jürgen Braun Harald Burkhardt Gerd R. Burmester Markus Gaubitz Angela Gause Erika Gromnica-Ihle Herbert Kellner Jens Kuipers Andreas Krause Hans-Martin Lorenz Bernhard Manger Hubert Nüßlein Hans-Georg Pott Andrea Rubbert-Roth Matthias Schneider Christof Specker Hendrik Schulze-Koops Hans-Peter Tony Siegfried Wassenberg Ulf Müller-Ladner 《Rheumatology international》2014,34(1):1-9
The German Society of Rheumatology approved new German guidelines for the sequential medical treatment of rheumatoid arthritis (RA) based on the European League Against Rheumatism (EULAR) recommendations for the management of RA published in 2010. An update of the EULAR systematic literature research was performed in Medline, Embase, and Cochrane databases. Meta-analyses, controlled trials, cohort studies, and registry data addressing traditional and biologic disease-modifying antirheumatic drugs, glucocorticoids, and treatment strategies published between January 2009 and August 2011 were included. Two reviewers independently evaluated and compared the additional data that had been published after the time limit set by the EULAR recommendations. A national guideline working group developed an adapted set of recommendations. The new German guidelines were accepted by vote using an informal Delphi approach. Twelve recommendations and the resulting updated treatment algorithm were developed and approved as a practical orientation for rheumatologists. These recommendations are based on a successive treatment with traditional and biologic disease-modifying drugs depending on the individual progress of the disease and distinct patient characteristics. The German guidelines have been developed on the basis of the internationally well-recognized EULAR recommendations. In addition, more recent evidence from a systematic literature research was considered. They have been developed and approved by a group of national experts aiming at guidance for rheumatologists to reach best medical practice. 相似文献
86.
Philipp Erben Juliana Schwaab Georgia Metzgeroth Hans-Peter Horny Mohamad Jawhar Karl Sotlar Alice Fabarius Martina Teichmann Sven Schneider Thomas Ernst Martin C. Müller Michelle Giehl Alexander Marx Karin Hartmann Andreas Hochhaus Wolf-Karsten Hofmann Nicholas C. P. Cross Andreas Reiter 《Annals of hematology》2014,93(1):81-88
The activating KIT D816V mutation plays a central role in the pathogenesis, diagnosis, and targeted treatment of systemic mastocytosis (SM). For improved and reliable identification of KIT D816V, we have developed an allele-specific quantitative real-time PCR (RQ-PCR) with an enhanced sensitivity of 0.01–0.1 %, which was superior to denaturing high-performance liquid chromatography (0.5–1 %) or conventional sequencing (10–20 %). Overall, KIT D816 mutations were identified in 146/147 (99 %) of patients (D816V, n?=?142; D816H, n?=?2; D816Y, n?=?2) with SM, including indolent SM (ISM, n?=?63, 43 %), smoldering SM (n?=?8, 5 %), SM with associated hematological non-mast cell lineage disease (SM-AHNMD, n?=?16, 11 %), and aggressive SM/mast cell leukemia?±?AHNMD (ASM/MCL, n?=?60, 41 %). If positive in BM, the KIT D816V mutation was found in PB of all patients with advanced SM (SM-AHNMD, ASM, and MCL) and in 46 % (23/50) of patients with ISM. There was a strong correlation between the KIT D816V expressed allele burden (KIT D816V EAB) with results obtained from DNA by genomic allele-specific PCR and also with disease activity (e.g., serum tryptase level), disease subtype (e.g., indolent vs. advanced SM) and survival. In terms of monitoring of residual disease, qualitative and quantitative assessment of KIT D816V and KIT D816V EAB was successfully used for sequential analysis after chemotherapy or allogeneic stem cell transplantation. We therefore conclude that RQ-PCR assays for KIT D816V are useful complimentary tools for diagnosis, disease monitoring, and evaluation of prognosis in patients with SM. 相似文献
87.
Jing Wang Jihong Lin Andreas Schlotterer Liang Wu Thomas Fleming Stephanie Busch Nadine Dietrich Hans-Peter Hammes 《Acta diabetologica》2014,51(5):813-821
Diabetes induces vasoregression, neurodegeneration and glial activation in the retina. Formation of advanced glycation endoproducts (AGEs) is increased in diabetes and contributes to the pathogenesis of diabetic retinopathy. CD74 is increased in activated microglia in a rat model developing both neurodegeneration and vasoregression. In this study, we aimed at investigating whether glucose and major AGE precursor methylglyoxal induce increased CD74 expression in the retina. Expression of CD74 in retinal microglia was analyzed in streptozotocin-diabetic rats by wholemount immunofluorescence. Nondiabetic mice were intravitreally injected with methylglyoxal. Expression of CD74 was studied by retinal wholemount immunofluorescence and quantitative real-time PCR, 48 h after the injection. CD74-positive cells were increased in diabetic 4-month retinas. These cells represented a subpopulation of CD11b-labeled activated microglia and were mainly located in the superficial vascular layer (13.7-fold increase compared to nondiabetic group). Methylglyoxal induced an 9.4-fold increase of CD74-positive cells in the superficial vascular layer and elevated gene expression of CD74 in the mouse retina 2.8-fold. In summary, we identified CD74 as a microglial activation marker in the diabetic retina. Exogenous methylglyoxal mimics the response in normoglycemic retina. This suggests that methylglyoxal is important in mediating microglial activation in the diabetic retina. 相似文献
88.
Aladdin H. Shadyab PhD JoAnn E. Manson MD DrPH Juhua Luo PhD Bernhard Haring MD MPH Nazmus Saquib PhD Linda G. Snetselaar RD PhD LD Jiu-Chiuan Chen MD ScD Erik J. Groessl PhD Sylvia Wassertheil-Smoller PhD Yangbo Sun MD PhD Lauren Hale PhD Meryl S. LeBoff MD Andrea Z. LaCroix PhD 《Journal of the American Geriatrics Society》2020,68(9):1970-1978
89.
Patricia Hirt-Minkowski Hans-Peter Marti Gideon Hönger Denis Grandgirard Stephen L. Leib Patrizia Amico Stefan Schaub 《Transplant immunology》2014,30(1):1-6
Progressive interstitial fibrosis and tubular atrophy (IF/TA) is a leading cause of chronic allograft dysfunction. Increased extracellular matrix remodeling regulated by matrix metalloproteases (MMPs) and their inhibitors (TIMPs) has been implicated in the development of IF/TA. The aim of this study was to investigate whether urinary/serum MMPs/TIMPs correlate with subclinical IF/TA detected in surveillance biopsies within the first 6 months post-transplant. We measured eight different MMPs/TIMPs simultaneously in urine and serum samples from patients classified as normal histology (n = 15), IF/TA 1 (n = 15) and IF/TA 2–3 (n = 10). There was no difference in urinary MMPs/TIMPs among the three groups, and only 1/8 serum MMPs/TIMPs (i.e. MMP-1) was significantly elevated in biopsies with IF/TA 2–3 (p = 0.01). In addition, urinary/serum MMPs/TIMPs were not different between surveillance biopsies demonstrating an early development of IF/TA (i.e. delta IF/TA ≥ 1 compared to a previous biopsy obtained three months before; n = 11) and stable grade of IF/TA (i.e. delta IF/TA = 0; n = 20). Next, we investigated whether urinary/serum MMP/TIMP levels are elevated during acute subclinical tubulitis in surveillance biopsies obtained within the first 6 months post-transplant (n = 25). Compared to biopsies with normal histology, serum MMPs/TIMPs were not different; however, all urinary MMP/TIMP levels were numerically higher during subclinical tubulitis (MMP-1, MMP-7, TIMP-1 with p ≤ 0.04). We conclude that urinary/serum MMPs/TIMPs do hardly correlate with existing or early developing IF/TA in surveillance biopsies obtained within the first 6 months post-transplant. This could be explained by the dynamic process of extracellular matrix remodeling, which seems to be active during acute tubulo-interstitial injury/inflammation, but not in quiescent IF/TA. 相似文献
90.